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Abstract 
Animal experiments have demonstrated the photocarcinogenic properties of 
furocoumarins, a group of naturally occurring chemicals that are rich in citrus 
products. We conducted a prospective study for citrus consumption and risk of basal 
cell carcinoma (BCC) and squamous cell carcinoma (SCC) of the skin based on data 
from 41,530 men in the Health Professionals Follow-up Study (1986-2010) and 
63,759 women in the Nurses' Health Study (1984-2010) who were free of cancers at 
baseline. Over 24-26 years of follow-up, we documented 20,840 incident BCCs and 
3544 incident SCCs. Compared to those who consumed citrus products less than 
twice per week, the pooled multivariable-adjusted hazard ratios were 1.03[95% 
confidence interval (95% CI): 0.99-1.08] for BCC and 1.14 (95% CI: 1.00-1.30) for 
SCC for those who consumed two to four times per week, 1.06 (95% CI: 1.01-1.11) 
for BCC and 1.15 (95% CI: 1.02-1.28) for SCC for five to six times per week, 1.11 
(95% CI: 1.06-1.16) for BCC and 1.22 (95% CI: 1.08-1.37) for SCC for once to 1.4 
times per day, and 1.16 (95% CI: 1.09-1.23) for BCC and 1.21 (95% Cl: 1.06-1.38) 
for SCC for 1.5 times per day or more (Ptrend=0.001 for BCC and 0.04 for SCC). Our 
findings support positive associations between citrus consumption and risk of 
cutaneous BCC and SCC in two cohorts of men and women, and call for further 
investigations to better understand the potential photocarcinogenesis associated with 
dietary intakes. 
Keywords: citrus fruit, furocoumarin, photocarcinogenesis, psoralen, skin cancer, sun 
exposure 
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Introduction 
Basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) of the skin are the 
most frequently diagnosed malignancies in the population (1,2). They are more 
common than all other cancers combined and can cause substantial morbidity and 
rising cost to the health-care system (3,4). Knowledge on the modifiable risk factors 
of these skin cancers is important for the prevention of cancer incidence. Solar 
ultraviolet (UV) radiation has been recognized as the major environmental factor for 
skin cancer. However, previous experimental studies suggest that certain photoactive 
agents, such as furocoumarins, may also increase the risk of skin cancer in the 
presence of UV radiation (5-11). Furocoumarins (furanocoumarins) are a group of 
naturally occurring chemicals that are rich in certain plants, including citrus products 
(12-15). Furocoumarins have high UV absorbance and mutagenic properties (16,17). 
Oral application of psoralens (a group of furocoumarin derivatives, e.g., 8-
methoxypsoralen and 5-methoxypsoralen/bergapten) and UVA radiation (PUVA) has 
been used as an effective therapy for severe psoriasis and other cutaneous problems 
(18,19). Interestingly, epidemiologic studies have demonstrated an increased risk of 
BCC and SCC among patients receiving PUVA treatment (8-10). Commonly 
consumed citrus products, such as grapefruit and orange, may contain varying 
amounts of psoralens/furocoumarins (12,13). However, whether dietary consumption 
of furocoumarin-rich foods may increase the risk of skin cancer is unknown. 
Our previous investigation based on data from two large ongoing cohort studies, 
the Health Professionals Follow-up Study (HPFS, 1986-2010) and the Nurses’ Health 
Study (NHS, 1984-2010), identified an increased risk of cutaneous malignant 
melanoma associated with citrus consumption (20). In the present study, we further 
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examined the association between citrus consumption and risk of two other major 
forms of skin cancer (i.e., BCC and SCC) in the HPFS and NHS. 
Methods 
Study Population 
The study population consisted of participants from two ongoing longitudinal cohort 
studies: HPFS and NHS. The HPFS consisted of 51,529 male health professionals 
who were aged 40 to 75 and completed their initial questionnaire in 1986. Information 
on medical history and lifestyle factors was collected biennially via mailed 
questionnaires in the two cohorts. The NHS was established in 1976 when 121,701 
married, registered, female nurses who were aged 30 to 55 years and residing in the 
United States at the time of enrollment responded to an initial questionnaire regarding 
their medical history and lifestyle risk factors. The present study was approved by the 
Institutional Review Boards of Brigham and Women’s Hospital and Harvard School 
of Public Health. We consider the participants’ completion and return of the self-
administered questionnaire as informed consent. 
We followed participants for incident BCC and SCC starting from 1986 in the 
HPFS and 1976 in the NHS. At baseline, 49,617 HPFS men and 81,685 NHS women 
completed the dietary questionnaires. Participants who had a history of cancer at 
baseline were excluded. Owing to small number and low risk of skin cancer in non-
white participants (1), the present study only included participants of Caucasian 
ancestries. After exclusions, 41,530 men and 63,759 women (total n=105,289) 
remained in the present study. 
Assessment of Dietary Consumption and Other Skin Cancer Risk factors 
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The present study used a food frequency questionnaire (FFQ) to collect dietary 
information every four years since 1986 in the HPFS and NHS, with an additional 
dietary questionnaire completed in 1984 in the NHS. Participants responded to the 
questions regarding how often on average (in nine categories ranging from never to 
six+ servings/d) during the previous year they had consumed grapefruit (“a half”), 
oranges (“one”), grapefruit juice and orange juice (“one small glass” of six fluid 
ounces), and other food items. Grapefruit and grapefruit juice were asked as a single 
item in the 2002 and 2006 FFQs. Overall citrus consumption was calculated as the 
sum of the reported frequencies of these individual citrus products. Dietary intake 
collected using the FFQ has been demonstrated to be a valid estimator of relative food 
intake when compared with multiple diet records (21,22).
 
The correlation coefficients 
ranged from 0.75 to 0.84 for the correlations between intakes of individual citrus 
products assessed on the baseline FFQ and intakes assessed on two 1-week dietary 
records (21).
 
Information on other dietary factors, including intakes of total energy, 
alcohol, coffee, other fruits and juices (13 items), and vegetables (26 items), was also 
collected by the FFQs. 
In the biennial follow-up questionnaires, we inquired and updated information 
on body weight and height, physical activity, cigarette smoking, and menopausal 
status and post-menopausal hormone use among women. Data on the following skin 
cancer risk related variables were also collected through the questionnaires (23,24): 
natural hair color at an early age; number of moles on arms; family history of 
melanoma in first-degree relatives; skin reaction to sun exposure for 2 hours or more 
as a child/adolescent; number of lifetime blistering sunburns; average time spent in 
direct sunlight since high school; cumulative UV flux at residence since baseline; and 
use of sunscreen. 
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Assessment of BCC and SCC Cases 
Biennial questionnaires mailed to all study participants included questions on 
diagnoses of BCC and SCC during the previous 2 years. We obtained permission 
from participants who reported new diagnoses of SCC to review their medical and 
pathological reports. Study physicians who were blinded of the exposure status 
reviewed the records to validate the diagnoses and retrieve information on tumor stage 
and location if available. SCCs were further classified into the following two 
subgroups according to tumor location: tumors occurred on the body sites with higher 
continuous sun exposure (head, neck and extremities), and tumors occurred on the 
body sites with lower continuous sun exposure (truncal sites including shoulder, back, 
hip, genitals, abdomen and chest). Although medical records were not obtained for 
self-reported BCC, previous validation studies have demonstrated high validity of 
self-reported BCC in the two cohorts, with 96% women and 84% men confirmed by 
pathological records (25,26). Over 2 million person-years of follow-up, we 
documented a total of 20,840 incident BCCs (9033 in men and 11,807 in women) and 
3544 incident SCCs (1540 in men and 2004 in women). SCCs include 2329 invasive 
cases and 1215 in-situ cases, among which 2758 occurred on the body sites with 
higher continuous sun exposure (head, neck and extremities) and 483 occurred on the 
body sites with lower continuous sun exposure (truncal sites). 
Statistical Analysis 
To create the best estimates of long-term intake and to minimize within-person 
variation, each dietary intake was calculated as the average of all reported intakes up 
to that time prior to every 2-year follow-up interval. Because grapefruit and grapefruit 
juice were asked as a single item in the 2002 and 2006 FFQs, analyses for separate 
grapefruit and grapefruit juice used cumulative average intakes up to 1998 for the 
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subsequent follow-up. We created a new intake variable for combined grapefruit and 
grapefruit juice for sensitivity analyses. Each participant contributed person-time from 
the return month of the baseline questionnaire to the date of the first report of any 
cancer, date of death, or the end of follow-up (January 1, 2010 for men; June 1, 2010 
for women), whichever came first. We used SAS software version 9.2 (SAS Institute 
Inc., Cary, North Carolina) for all statistical analyses. All statistical tests were two-
tailed, and the significance level was set at P<0.05. 
Cox proportional hazards models were used to compute the hazard ratios (HR) 
with 95% confidence intervals (CI) of BCC and SCC associated with dietary intakes. 
Multivariable analyses were performed with adjustment for other skin cancer risk 
factors and potential lifestyle and dietary confounders. We used the most recent 
information for time-varying variables (e.g., body mass index) prior to each follow-up 
interval to take into account potential changes over the follow-up. Missing data during 
any follow-up period were coded as a missing indicator category for categorical 
variables (e.g., smoking status) and with carried-forward values for continuous 
variables (e.g., body mass index).
 
Trend tests for a given citrus product were 
performed by assigning median values for citrus intake categories and treating the 
new variable as a continuous term in the models. The analyses were performed among 
men and women separately and then pooled using a random-effects model. We also 
performed analyses for SCC subtypes divided by tumor stage and site. The two 
highest consumption categories for each citrus variable were combined to maintain 
the statistical power in subtype analyses. 
Several sensitivity analyses were performed to test the specificity and 
consistency of the reported associations. To examine whether the positive association 
with risk of BCC and SCC was specific to citrus products, we computed the HRs of 
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BCC and SCC in association with consumption of non-citrus fruits and juices and 
vegetables. To address the concern about potential reverse causality between dietary 
assessment and cancer diagnosis, we performed lag analyses by adding a 2-year 
interval between dietary intake and cohort follow-up (e.g., we used citrus 
consumption from the 1984 questionnaire for the follow-up period from 1986 to 1988 
in the NHS). 
Results 
Table 1 shows the baseline characteristics of the study population. There was no 
appreciable difference in known skin cancer risk factors including phenotypic traits 
(e.g., red/blonde hair color and skin reaction to sun as a child/adolescent) and sun 
exposure related variables (i.e., number of lifetime blistering sunburns, average time 
spent in direct sunlight since high school and annual UV flux at residence) over the 
citrus intake categories, suggesting homogeneous characteristics of the study 
participants in terms of host risk profile and sun exposure. Consumption levels of 
citrus products remained relatively constant over the follow-up, and orange juice was 
the major contributor of overall citrus consumption (Table S1). 
No significant heterogeneity was detected between sex-specific results for BCC 
and SCC (Table S2 & Table S3, all P for heterogeneity>0.05), and therefore the 
pooled risk estimates were presented as the main results. Overall citrus consumption 
was significantly associated with increased risk of BCC in the pooled analyses (Table 
2). Among the individual citrus products, grapefruit and orange juice showed 
significant positive associations with risk of BCC. Neither grapefruit juice nor 
oranges was significantly associated with risk of BCC. Similarly, overall citrus 
consumption was also positively associated with risk of SCC (Table 3). Among the 
Ac
ce
pt
ed
 M
an
us
cr
ipt
9 
individual citrus products, grapefruit showed the most apparent association with risk 
of SCC, followed by orange juice, and neither grapefruit juice nor oranges was 
significantly associated with risk of SCC. 
Associations between citrus consumption and risk of BCC and SCC remained 
essentially unchanged when we added a 2-year lag between dietary assessment and 
cohort follow-up (data not shown). Subtype analyses for SCC showed similar 
associations with citrus consumption for invasive and in-situ cases (data not shown). 
Interestingly, the positive association of SCC with citrus consumption appeared to be 
more apparent for tumors occurred on the body sites with higher continuous sun 
exposure (head, neck and extremities) than for tumors occurred on the body sites with 
lower continuous sun exposure (truncal sites) (Table 4). There were significant trends 
towards higher risk for SCC on head, neck and extremities (all Ptrend<0.05) but not for 
SCC on truncal sites (all Ptrend>0.50) in association with consumption of overall citrus, 
grapefruit and orange juice. 
We did not find any significant positive association between consumption of 
other non-citrus fruits, juices and vegetables and risk of BCC or SCC (data not 
shown). Instead, we found primarily inverse associations between these food items 
and disease risk. For example, the fully-adjusted HRs comparing the extreme 
consumption categories of total non-citrus fruit and juice (13 items, ≥3.0/d vs. <0.75/d) 
were 0.90 (95% CI: 0.84-0.96, Ptrend=0.049) for BCC and 0.87 (95% CI: 0.74-1.03, 
Ptrend=0.06) for SCC. 
We conducted interaction tests to evaluate whether the association between 
citrus consumption and risk of SCC and BCC varied by other potential confounders, 
and found that there was no significant interaction between citrus consumption and 
other variables adjusted in the analysis (all Pinteraction>0.10, data not shown). We 
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further examined the risk of other major non-skin cancers (e.g., breast cancer, prostate 
cancer, lung cancer and colorectal cancer) in association with citrus consumption, and 
did not find any similar positive associations (data not shown). 
Discussion 
In the present study, we performed a detailed analysis for the association between 
citrus consumption and risk of cutaneous BCC and SCC based on data from two large 
cohorts of men and women. After adjusting for other known skin cancer risk factors 
and potential confounders, citrus consumption was positively associated with 
increased risk of BCC and SCC. Among the individual citrus product , grapefruit and 
orange juice showed consistent positive associations with risk of BCC and SCC. 
These findings are generally consistent with our previous investigation for citrus 
consumption and risk of cutaneous malignant melanoma (20), both of which support a 
potentially increased risk of skin cancer associated with consumption of 
furocoumarin-containing foods. 
The potential photocarcinogenesis of furocoumarins has well-documented 
biological plausibility. Furocoumarins/psoralens have been identified as a group of 
carcinogens for decades (5,7). Previous animal experiments have well demonstrated 
that furocoumarins are able to induce skin tumors in the presence of UV radiation (5-
7,11). Mechanistic investigations have revealed a linear relation between epidermal 
and serum concentrations of psoralens after oral administration, and the appearance of 
phototoxicity is associated with the serum concentrations of psoralens (27). 
Furocoumarins plus UV radiation could induce skin erythema, edema, delayed 
pigmentation, and increased activity of epidermal ornithine decarboxylase, which may 
serve as a biomarker for cutaneous tumor promotion (28,29). Furocoumarins could 
also induce lethal, mutagenic and clastogenic effects in mammalian cells and other 
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organisms (16,17). Photoexcited furocoumarins can react with biomolecules, 
especially with pyrimidine bases in DNA, and form mono- and di-adducts (30,31), 
and photocycloaddition reactions initiated by furocoumarins play an important role in 
the formation of  DNA adducts (18). Although DNA is generally assumed as the 
primary site of action for furocoumarins (31,32), they may also bind to other specific 
and high-affinity sites in mammalian cells which may in turn mediate the 
furocoumarin-induced phototoxicity in part (33). 
Citrus products are known to contain furocoumarins (12-15), and orange and 
grapefruit are the two mostly consumed citrus fruits in the population over the past 
several decades, accounting for over 90% of citrus market shares (34). Although 
grapefruit and orange juice were significantly and positively associated with risk of 
BCC and SCC, grapefruit juice and oranges did not showed appreciable positive 
associations with these outcome diseases. Several reasons may help explain the 
different associations. Grapefruit generally contains higher levels of furocoumarins 
than oranges (12,13). The null association of grapefruit juice with skin cancer risk 
may be explained by its much lower consumption levels (Table S1) and a much larger 
number of non-consumers (Table 2) when compared to the other individual citrus 
products. In contrast, orange juice contributed to more than 50% of the overall citrus 
consumption, and the significant association of orange juice with skin cancer risk may 
be explained by its much higher consumption levels when compared to the other 
individual citrus products (Table S1). 
In addition, we found that the positive association between citrus consumption 
and SCC risk appeared to be more apparent for tumors occurred on the body sites 
with higher continuous sun exposure (head, neck and extremities) than for tumors 
occurred on the body sites with lower continuous sun exposure (truncal sites). 
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Interestingly, animal experiments have demonstrated that exposure to furocoumarins 
or UVA alone is not tumorigenic in mice whereas exposure to furocoumarins plus 
UVA substantially increases the number of mice with skin tumors (6,11). Therefore, 
our findings may suggest a potential synergistic effect between citrus consumption 
and UV radiation. 
Our study has several strengths, including the prospective design, the large 
sample size and large number of skin cancer cases, the long-term follow-up over 24-
26 years, the repeated assessment of dietary and lifestyle factors, and the ability to 
include a number of potential confounders. Nevertheless, our study also has several 
limitations. Our study populations consisted of well-educated Caucasian health 
professionals and may not be representative of the general population. Nevertheless, 
restricting the sample to health professionals also reduces potential residual 
confounding from socioeconomic status. Our results need to be replicated in future 
studies with sufficient power to detect similar associations among other populations. 
In addition, the diagnosis of BCC was assessed based on self-reports without 
pathological validation. However, the health care background of our study 
participants suggest that their reports were likely to be highly accurate, as proven in 
previous validation studies (25,26). The positive association between citrus 
consumption and BCC risk as reported herein is also consistent between the two study 
cohorts. These data suggest that the bias due to self-reported BCC is likely to be 
minimal and unlikely to affect the study results materially. Furthermore, we do not 
have data on exposure to arsenic, which has been linked to the risk of skin cancer (35). 
However, our study participants have better health awareness than the general 
population and are therefore less likely to be exposed to arsenic, either occupationally 
or non-occupationally. 
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In conclusion, our study based on two large cohorts of men and women 
demonstrated that citrus consumption was associated with an increased risk of 
cutaneous BCC and SCC, the most commonly diagnosed malignancies in the 
population. These findings together with our previous investigation on citrus 
consumption and risk of cutaneous malignant melanoma (20) provide evidence for the 
potential photocarcinogenic effect of commonly consumed foods. However, our study 
findings need to be confirmed in future studies before a clear causal inference could 
be obtained. Nevertheless, given  the high prevalence of citrus consumption as well as 
skin cancers in the population, our findings hold general public health significance 
and may serve as the first effort to initiate future research in this area. 
Ac
ce
pt
ed
 M
an
us
cr
ipt
14 
Acknowledgements 
We would like to thank the participants and staff of the Nurses’ Health Study and 
Health Professionals Follow-up Study for their valuable contributions as well as the 
following state cancer registries for their help: AL, AZ, AR, CA, CO, CT, DE, FL, 
GA, ID, IL, IN, IA, KY, LA, ME, MD, MA, MI, NE, NH, NJ, NY, NC, ND, OH, OK, 
OR, PA, RI, SC, TN, TX, VA, WA, WY. The authors assume full responsibility for 
analyses and interpretation of these data.  
Funding 
The work was supported by National Institute of Health grants (No. UM1 CA186107, 
P01 CA87969, UM1 CA167552 and R01 CA137165). 
Disclosure 
The authors declared no conflict of interest. 
Ac
ce
pt
ed
 M
an
us
cr
ipt
15 
References 
1. American Cancer Society (2014) Cancer Facts & Figures 2014. In Society, A.C. (ed.),
Atlanta.
2. Wehner, M.R., et al. (2012) Indoor tanning and non-melanoma skin cancer:
systematic review and meta-analysis. Bmj, 345, e5909.
3. Rogers, H.W., et al. (2010) Incidence estimate of nonmelanoma skin cancer in the
United States, 2006. Arch Dermatol, 146, 283-7.
4. Guy, G.P., et al. (2011) Years of potential life lost and indirect costs of melanoma and
non-melanoma skin cancer: a systematic review of the literature.
Pharmacoeconomics, 29, 863-74.
5. Griffin, A.C., et al. (1958) The wave length effect upon erythemal and carcinogenic
response in psoralen treated mice. J Invest Dermatol, 31, 289-95.
6. Cartwright, L.E., et al. (1983) Psoralen-containing sunscreen is tumorigenic in
hairless mice. J Am Acad Dermatol, 8, 830-6.
7. Mullen, M.P., et al. (1984) Carcinogenic effects of monofunctional and bifunctional
furocoumarins. Natl Cancer Inst Monogr, 66, 205-10.
8. Stern, R.S., et al. (1984) Cutaneous squamous-cell carcinoma in patients treated with
PUVA. N Engl J Med, 310, 1156-61.
9. Stern, R.S., et al. (1998) Oral psoralen and ultraviolet-A light (PUVA) treatment of
psoriasis and persistent risk of nonmelanoma skin cancer. PUVA Follow-up Study. J
Natl Cancer Inst, 90, 1278-84.
10. Stern, R.S. (2012) The risk of squamous cell and basal cell cancer associated with
psoralen and ultraviolet A therapy: a 30-year prospective study. J Am Acad Dermatol,
66, 553-62.
11. Zajdela, F., et al. (1981) 5-Methoxypsoralen, the melanogenic additive in sun-tan
preparations, is tumorigenic in mice exposed to 365 nm u.v. radiation.
Carcinogenesis, 2, 121-7.
12. Dugo, P., et al. (2000) LC-MS for the identification of oxygen heterocyclic
compounds in citrus essential oils. J Pharm Biomed Anal, 24, 147-54.
13. Dugo, P., et al. (2009) Determination of oxygen heterocyclic components in citrus
products by HPLC with UV detection. J Agric Food Chem, 57, 6543-51.
14. Frerot, E., et al. (2004) Quantification of total furocoumarins in citrus oils by HPLC
coupled with UV, fluorescence, and mass detection. J Agric Food Chem, 52, 6879-86.
15. Lin, Y.K., et al. (2009) Development of a reversed-phase high-performance liquid
chromatographic method for analyzing furanocoumarin components in citrus fruit
juices and Chinese herbal medicines. J Chromatogr Sci, 47, 211-5.
16. Ashwood-Smith, M.J., et al. (1980) 5-Methoxypsoralen, an ingredient in several
suntan preparations, has lethal, mutagenic and clastogenic properties. Nature, 285,
407-9.
17. Scott, B.R., et al. (1976) Molecular and genetic basis of furocoumarin reactions.
Mutat Res, 39, 29-74.
18. Kitamura, N., et al. (2005) Molecular aspects of furocoumarin reactions:
Photophysics, photochemistry, photobiology, and structural analysis. Journal of
Photochemistry and Photobiology C: Photochemistry Reviews, 6, 168-185.
19. Parrish, J.A., et al. (1974) Photochemotherapy of psoriasis with oral methoxsalen and
longwave ultraviolet light. N Engl J Med, 291, 1207-11.
Ac
ce
pt
ed
 M
an
us
cr
ipt
16 
20. Wu, S., et al. (2015, in press) Citrus consumption and risk of cutaneous malignant
melanoma. Journal of Clinical Oncology.
21. Feskanich, D., et al. (1993) Reproducibility and validity of food intake measurements
from a semiquantitative food frequency questionnaire. Journal of the American
Dietetic Association, 93, 790-796.
22. Salvini, S., et al. (1989) Food-based validation of a dietary questionnaire: the effects
of week-to-week variation in food consumption. Int J Epidemiol, 18, 858-67.
23. Wu, S., et al. (2013) Basal-cell carcinoma incidence and associated risk factors in
U.S. women and men. Am J Epidemiol, 178, 890-7.
24. Geller, A.C., et al. (2002) Melanoma incidence and mortality among US whites,
1969-1999. Jama, 288, 1719-20.
25. Colditz, G.A., et al. (1986) Validation of questionnaire information on risk factors
and disease outcomes in a prospective cohort study of women. Am J Epidemiol, 123,
894-900.
26. van Dam, R.M., et al. (2000) Diet and basal cell carcinoma of the skin in a
prospective cohort of men. Am J Clin Nutr, 71, 135-41.
27. Kornhauser, A., et al. (1982) Psoralen phototoxicity: correlation with serum and
epidermal 8-methoxypsoralen and 5-methoxypsoralen in the guinea pig. Science, 217,
733-5.
28. Lowe, N.J. (1980) Epidermal ornithine decarboxylase, polyamines, cell proliferation,
and tumor promotion. Arch Dermatol, 116, 822-5.
29. Walter, J.F., et al. (1982) Psoralen-containing sunscreen induces phototoxicity and
epidermal ornithine decarboxylase activity. J Am Acad Dermatol, 6, 1022-7.
30. Tessman, J.W., et al. (1985) Photochemistry of the furan-side 8-methoxypsoralen-
thymidine monoadduct inside the DNA helix. Conversion to diadduct and to pyrone-
side monoadduct. Biochemistry, 24, 1669-76.
31. Vos, J.M., et al. (1987) Processing of psoralen adducts in an active human gene:
repair and replication of DNA containing monoadducts and interstrand cross-links.
Cell, 50, 789-99.
32. Dall'Acqua, F., et al. (1971) Formation of inter-strand cross-linkings in the
photoreaction between furocoumarins and DNA. Z Naturforsch B, 26, 561-9.
33. Laskin, J.D., et al. (1985) A possible mechanism of psoralen phototoxicity not
involving direct interaction with DNA. Proc Natl Acad Sci U S A, 82, 6158-62.
34. US Department of Agriculture Economic Research Service (2014) Fruit and tree nut
data. Available at: http://www.ers.usda.gov/data-products/fruit-and-tree-nut-
data/yearbook-tables.aspx.
35. Surdu, S. (2014) Non-melanoma skin cancer: occupational risk from UV light and
arsenic exposure. Rev Environ Health, 29, 255-64.
Ac
ce
pt
ed
 M
an
us
cr
ipt
17 
Table 1. Baseline Characteristics of Study Participants According to Frequency of Overall Citrus Consumption in the HPFS and NHS. 
<2/wk 2-4/wk 5-6/wk 1-1.4/d ≥1.5/d 
Men (1986) 
No. of participants 10,617 6236 6921 9496 8260 
Age (year)
a
 52.0(9.2) 52.2(9.4) 53.3(9.6) 54.3(9.8) 54.7(9.8) 
Red/blonde hair, % 13.3 14.2 13.0 13.8 12.6 
Arm with moles, % 31.4 32.2 32.7 31.9 32.0 
Painful burn/blisters skin reaction as a child/adolescent, % 23.7 23.7 23.9 24.0 22.7 
Family history of melanoma, % 4.2 3.6 3.9 4.3 3.7 
No. of lifetime blistering sunburns 13.0(12.0) 13.1(12.1) 13.1(12.1) 12.6(12.0) 12.6(12.2) 
Average time spent in direct sunlight since high school (hrs/wk) 9.2(5.4) 9.1(5.3) 9.2(5.4) 9.1(5.5) 9.0(5.6) 
Annual UV flux at residence (×10
-4
 RB count) 132.0(27.5) 130.1(27.1) 129.1(26.7) 127.4(26.2) 126.3(26.2) 
Body mass index (kg/m
2
) 25.1(5.2) 25.1(5.3) 25.1(5.1) 24.9(4.6) 24.8(5.0) 
Physical activity level (metabolic-equivalents hrs/wk) 17.1(27.0) 19.7(29.3) 21.1(30.7) 22.0(28.9) 25.8(32.3) 
Current smoker, % 14.1 10.1 8.4 7.7 6.3 
Alcohol intake (g/d) 12.6(17.9) 11.8(16.0) 11.8(15.8) 11.8(15.2) 10.6(14.6) 
Coffee (cup/d) 1.6(1.8) 1.4(1.6) 1.3(1.5) 1.2(1.5) 1.1(1.4) 
Women (1984) 
No. of participants 17,660 10,217 9771 15,269 10,842 
Age (year)
a
 49.2(7.1) 49.5(7.2) 50.0(7.2) 50.7(7.2) 51.3(7.0) 
Red/blonde hair, % 15.5 16.1 15.4 15.4 16.6 
Arm with moles, % 36.5 37.6 36.5 37.5 39.2 
Painful burn/blisters skin reaction as a child/adolescent, % 15.6 14.8 14.0 13.8 14.6 
Family history of melanoma, % 6.7 6.8 7.1 7.3 7.3 
No. of lifetime blistering sunburns 8.6(7.0) 8.8(7.0) 8.8(6.9) 8.7(6.9) 8.6(7.0) 
Average time spent in direct sunlight since high school (hrs/wk) 4.8(2.7) 4.9(2.7) 5.0(2.7) 4.9(2.7) 5.0(2.7) 
Annual UV flux at residence (×10
-4
 RB count) 124.4(25.9) 123.0(25.1) 122.0(24.3) 119.7(23.0) 118.8(22.1) 
Body mass index (kg/m2) 25.0(4.9) 25.3(4.8) 25.2(4.7) 24.9(4.7) 25.0(4.8) 
Physical activity level (metabolic-equivalents hrs/wk) 12.1(19.7) 13.1(18.8) 14.1(19.1) 14.2(19.1) 17.3(24.6) 
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Current smoker, % 32.1 25.2 21.0 20.0 18.6 
Menopausal status, % 46.5 46.1 45.8 45.9 46.3 
Postmenopausal hormone use,b % 24.5 24.0 25.0 24.9 24.8 
Alcohol intake (g/d) 7.2(12.7) 6.7(11.4) 6.9(11.0) 7.3(11.3) 7.1(11.0) 
Coffee (cup/d) 1.9(1.9) 1.8(1.8) 1.7(1.7) 1.6(1.6) 1.6(1.7) 
NOTE: Values are means (SD) or percentages and have been standardized to the age distribution of the study population. 
a
 Values are not age adjusted. 
b
 Percentages among postmenopausal women. 
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Table 2. Pooled Risk of Basal Cell Carcinoma According to Frequency of Citrus Consumption in the HPFS (1986-2010) and NHS (1984-
2010). 
Serving category P for trend 
Overall citrus <2/wk 2-4/wk 5-6/wk 1-1.4/d ≥1.5/d 
No. of person-years 400,456 371,958 465,228 418,628 319,669 
No. of cases 3505 3665 5022 4787 3861 
Age-adjusted HR (95% CI) 1.00 1.07 (0.99-1.16) 1.11 (1.06-1.16) 1.17 (1.12-1.22) 1.20 (1.15-1.26) <0.001 
Multivariable-adjusted HR1 (95% CI) 1.00 1.03 (0.99-1.08) 1.06 (1.01-1.11) 1.11(1.06-1.16) 1.16 (1.09-1.23) 0.001 
Grapefruit Never <1/wk 1/wk 2/wk ≥3/wk 
No. of person-years 509,252 639,008 349,832 221,228 256,619 
No. of cases 4507 6460 3827 2795 3251 
Age-adjusted HR (95% CI) 1.00 1.08 (1.04-1.13) 1.15 (1.10-1.20) 1.21 (1.15-1.27) 1.19 (1.14-1.25) <0.001 
Multivariable-adjusted HR1 (95% CI) 1.00 1.03 (0.99-1.08) 1.09 (1.02-1.17) 1.13 (1.07-1.19) 1.13 (1.05-1.21) <0.001 
Multivariable-adjusted HR2 (95% CI) 1.00 1.03 (0.99-1.08) 1.09 (1.01-1.18) 1.13 (1.06-1.20) 1.14 (1.04-1.24) 0.002 
Grapefruit juice Never <1/wk 1/wk 2/wk ≥3/wk 
  No. of person-years 1,092,966 476,005 165,397 110,093 131,479 
  No. of cases 11,062 5256 1768 1278 1476 
  Age-adjusted HR (95% CI) 1.00 1.05 (1.00-1.11) 1.03 (0.98-1.08) 1.07 (1.01-1.13) 1.08 (1.02-1.15) 0.01 
  Multivariable-adjusted HR1 (95% CI) 1.00 1.00 (0.96-1.04) 0.99 (0.94-1.04) 1.02 (0.96-1.08) 1.06 (1.00-1.12) 0.08 
Multivariable-adjusted HR2 (95% CI) 1.00 0.98 (0.93-1.04) 0.96 (0.91-1.01) 0.98 (0.92-1.04) 1.02 (0.97-1.08) 0.80 
Oranges Never <1/wk 1/wk 2/wk ≥3/wk 
  No. of person-years 228,853 518,773 401,333 338,726 488,254 
  No. of cases 2213 5157 4075 3940 5455 
  Age-adjusted HR (95% CI) 1.00 1.00 (0.95-1.06) 1.03 (0.97-1.08) 1.07 (0.93-1.25) 1.03 (0.94-1.12) 0.37 
  Multivariable-adjusted HR1 (95% CI) 1.00 0.96 (0.91-1.01) 0.95 (0.90-1.01) 0.97 (0.86-1.10) 0.94 (0.86-1.03) 0.59 
Multivariable-adjusted HR2 (95% CI) 1.00 0.95 (0.90-1.00) 0.94 (0.89-1.00) 0.96 (0.84-1.10) 0.93 (0.84-1.04) 0.56 
Orange juice <1/wk 1-2/wk 3-4/wk 5-6/wk ≥1/d 
  No. of person-years 499,507 451,276 395,566 310,206 319,385 
  No. of cases 4723 4567 4223 3706 3621 
  Age-adjusted HR (95% CI) 1.00 1.05 (1.01-1.09) 1.09 (1.04-1.13) 1.15 (1.10-1.20) 1.17 (1.12-1.22) <0.001 
  Multivariable-adjusted HR1 (95% CI) 1.00 1.02 (0.97-1.06) 1.06 (1.01-1.10) 1.09 (1.04-1.14) 1.13 (1.05-1.21) <0.001 
Multivariable-adjusted HR2 (95% CI) 1.00 1.01 (0.97-1.05) 1.05 (1.01-1.10) 1.08 (1.03-1.14) 1.12 (1.05-1.20) <0.001 
NOTE: Multivariable hazard ratios were adjusted for age, natural hair color (red, blonde, light brown, dark brown, black), number of arm moles (0, 1-
2, 3-9, ≥10), sunburn susceptibility as a child/adolescent (none/some redness, burn, painful burn/blisters), family history of melanoma (yes, no), 
number of lifetime blistering sunburns (0, 1-4, 5-9, ≥10), cumulative UV flux since baseline (quintiles), average time spent in direct sunlight since 
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high school (<2, 2-5, 6-10, ≥11 hrs/wk), sunscreen use (yes, no), body mass index (<25.0, 25.0-29.9, 30.0-34.9, ≥35.0 kg/m2), physical activity 
(quintiles), smoking status (never, past, current with 1-14, 15-24, or ≥25 cigarettes/d), alcohol intake (0, 0.1-4.9, 5.0-9.9, 10.0-19.9, ≥20.0 g/d), coffee 
intake (0, <1, 1, 2, ≥3 cup/d), and consumption of total other fruit and juice (except citrus products, <0.75, 0.75-1.2, 1.3-1.9, 2.0-2.9, ≥3.0/d) and total 
vegetable (<2.0, 2.0-2.9, 3.0-3.9, 4.0-4.9, ≥5.0/d). Analyses for women were also adjusted for menopausal status and postmenopausal hormone use 
(premenopausal, postmenopausal never, past, or current use). The second multivariable hazard ratios were additionally adjusted for consumption of 
the other individual citrus products listed in the tables. Results in the HPFS and NHS were pooled using the random-effects model. 
Abbreviations: CI, confidence interval; HR, hazard ratio. 
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Table 3. Pooled Risk of Squamous Cell Carcinoma According to Frequency of Citrus Consumption in the HPFS (1986-2010) and NHS (1984-
2010). 
Serving category P for trend 
Overall citrus <2/wk 2-4/wk 5-6/wk 1-1.4/d ≥1.5/d 
No. of person-years 400,456 371,958 465,228 418,628 319,669 
No. of cases 530 672 913 825 604 
Age-adjusted HR (95% CI) 1.00 1.19 (1.02-1.39) 1.20 (1.07-1.33) 1.26 (1.13-1.41) 1.20 (1.07-1.35) 0.001 
Multivariable-adjusted HR1 (95% CI) 1.00 1.14 (1.00-1.30) 1.15 (1.02-1.28) 1.22 (1.08-1.37) 1.21 (1.06-1.38) 0.04 
Grapefruit Never <1/wk 1/wk 2/wk ≥3/wk 
No. of person-years 509,252 639,008 349,832 221,228 256,619 
No. of cases 635 1182 641 530 556 
Age-adjusted HR (95% CI) 1.00 1.26 (1.14-1.39) 1.24 (1.09-1.42) 1.34 (1.19-1.51) 1.33 (1.18-1.49) <0.001 
Multivariable-adjusted HR1 (95% CI) 1.00 1.16 (1.05-1.28) 1.15 (0.93-1.41) 1.23 (1.05-1.45) 1.30 (1.14-1.48) <0.001 
Multivariable-adjusted HR2 (95% CI) 1.00 1.16 (1.04-1.28) 1.15 (0.94-1.41) 1.25 (1.07-1.47) 1.31 (1.15-1.49) <0.001 
Grapefruit juice Never <1/wk 1/wk 2/wk ≥3/wk 
  No. of person-years 1,092,966 476,005 165,397 110,093 131,479 
  No. of cases 1776 988 301 212 267 
  Age-adjusted HR (95% CI) 1.00 1.10 (1.02-1.19) 1.00 (0.87-1.14) 0.95 (0.82-1.09) 1.17 (0.97-1.40) 0.37 
  Multivariable-adjusted HR1 (95% CI) 1.00 1.03 (0.95-1.11) 0.96 (0.84-1.11) 0.90 (0.78-1.04) 1.17 (1.02-1.36) 0.42 
Multivariable-adjusted HR2 (95% CI) 1.00 0.99 (0.91-1.07) 0.91 (0.80-1.04) 0.84 (0.73-0.98) 1.11 (0.97-1.27) 0.85 
Oranges Never <1/wk 1/wk 2/wk ≥3/wk 
  No. of person-years 228,853 518,773 401,333 338,726 488,254 
  No. of cases 295 892 747 752 858 
  Age-adjusted HR (95% CI) 1.00 1.11 (0.97-1.27) 1.20 (1.05-1.38) 1.16 (1.01-1.33) 1.02 (0.89-1.17) 0.45 
  Multivariable-adjusted HR1 (95% CI) 1.00 1.01 (0.88-1.16) 1.06 (0.92-1.22) 1.01 (0.87-1.17) 0.93 (0.80-1.08) 0.12 
Multivariable-adjusted HR2 (95% CI) 1.00 0.99 (0.86-1.13) 1.04 (0.90-1.20) 0.99 (0.85-1.15) 0.91 (0.78-1.06) 0.12 
Orange juice <1/wk 1-2/wk 3-4/wk 5-6/wk ≥1/d 
  No. of person-years 499,507 451,276 395,566 310,206 319,385 
  No. of cases 723 816 768 662 575 
  Age-adjusted HR (95% CI) 1.00 1.10 (0.95-1.26) 1.17 (1.00-1.36) 1.15 (1.03-1.28) 1.22 (1.10-1.37) <0.001 
  Multivariable-adjusted HR1 (95% CI) 1.00 1.04 (0.94-1.15) 1.12 (1.01-1.24) 1.06 (0.95-1.18) 1.18 (1.06-1.32) 0.009 
Multivariable-adjusted HR2 (95% CI) 1.00 1.03 (0.93-1.14) 1.11 (0.99-1.23) 1.05 (0.94-1.17) 1.17 (1.05-1.31) 0.01 
NOTE: Multivariable hazard ratios were further adjusted for the covariates listed in the Table 2 footnote. Results in the HPFS and NHS were pooled 
using the random-effects model. 
Abbreviations: CI, confidence interval; HR, hazard ratio. 
Ac
ce
pt
ed
 M
an
us
cr
ipt
22 
Table 4. Pooled Risk of Site-Specific Squamous Cell Carcinoma According to Frequency of Citrus Consumption in the HPFS (1986-2010) 
and NHS (1984-2010). 
Serving category P for trend 
Overall citrus <2/wk 2-4/wk 5-6/wk ≥1/d 
No. of person-years 400,456 371,958 465,228 738,297 
Risk of SCC on the body sites with higher continuous sun exposure (head, neck and extremities) 
No. of cases 406 526 722 1104 
Multivariable-adjusted HR (95% CI) 1.00 1.15 (1.01-1.32) 1.17 (1.02-1.33) 1.23 (1.08-1.39) 0.004 
Risk of SCC on the body sites with lower continuous sun exposure (truncal sites) 
No. of cases 78 91 126 188 
Multivariable-adjusted HR (95% CI) 1.00 1.01 (0.74-1.38) 1.07 (0.63-1.81) 1.07 (0.76-1.50) 0.70 
Grapefruit Never <1/wk 1/wk ≥2/wk 
No. of person-years 509,252 639,008 349,832 477,847 
Risk of overall SCC on the body sites with higher continuous sun exposure (head, neck and extremities)
No. of cases 471 935 496 856 
Multivariable-adjusted HR (95% CI) 1.00 1.21 (1.08-1.36) 1.18 (0.94-1.47) 1.33 (1.15-1.53) 0.01 
Risk of overall SCC on the body sites with lower continuous sun exposure (truncal sites) 
No. of cases 93 167 84 139 
Multivariable-adjusted HR (95% CI) 1.00 1.09 (0.83-1.43) 1.03 (0.75-1.43) 1.15 (0.84-1.57) 0.58 
Grapefruit juice Never <1/wk 1/wk ≥2/wk 
No. of person-years 1,092,966 476,005 165,397 241,572 
Risk of overall SCC on the body sites with higher continuous sun exposure (head, neck and extremities) 
No. of cases 1364 765 236 393 
Multivariable-adjusted HR (95% CI) 1.00 0.97 (0.88-1.06) 0.91 (0.79-1.05) 1.02 (0.91-1.15) 0.89 
Risk of overall SCC on the body sites with lower continuous sun exposure (truncal sites) 
No. of cases 247 140 45 51 
Multivariable-adjusted HR (95% CI) 1.00 0.99 (0.80-1.24) 0.98 (0.65-1.47) 0.74 (0.54-1.02) 0.18 
Oranges Never <1/wk 1/wk ≥2/wk 
No. of person-years 228,853 518,773 401,333 826,980 
Risk of overall SCC on the body sites with higher continuous sun exposure (head, neck and extremities) 
No. of cases 210 699 603 1246 
Multivariable-adjusted HR (95% CI) 1.00 1.03 (0.88-1.21) 1.10 (0.93-1.30) 0.96 (0.81-1.13) 0.41 
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Risk of overall SCC on the body sites with lower continuous sun exposure (truncal sites) 
No. of cases 43 117 92 231 
Multivariable-adjusted HR (95% CI) 1.00 0.82 (0.57-1.18) 0.80 (0.54-1.18) 0.88 (0.60-1.29) 0.97 
Orange juice <1/wk 1-2/wk 3-4/wk ≥5/wk 
No. of person-years 499,507 451,276 395,566 629,591 
Risk of overall SCC on the body sites with higher continuous sun exposure (head, neck and extremities)
No. of cases 542 656 587 973 
Multivariable-adjusted HR (95% CI) 1.00 1.06 (0.93-1.21) 1.10 (0.96-1.25) 1.13 (1.01-1.26) 0.03 
Risk of overall SCC on the body sites with lower continuous sun exposure (truncal sites) 
No. of cases 102 107 111 163 
Multivariable-adjusted HR (95% CI) 1.00 0.92 (0.70-1.21) 1.13 (0.75-1.72) 1.02 (0.64-1.64) 0.73 
NOTE: Multivariable hazard ratios were adjusted for the covariates listed in the Table 2 footnote. Results in the HPFS and NHS were pooled using 
the random-effects model. 
Abbreviations: CI, confidence interval; HR, hazard ratio.  
